Schmidt N, Brune K, Geisslinger G
Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Germany.
Eur J Pharmacol. 1994 Apr 1;255(1-3):245-7. doi: 10.1016/0014-2999(94)90105-8.
It has been suggested that morphine-6-glucuronide, a major metabolite of the opioid analgesic morphine, is more potent as an analgesic than the parent drug. This finding appears not to be due to differences in affinity for opioid receptors. Therefore, in the present study the opioid receptor mediated effects of morphine and morphine-6-glucuronide were compared in vitro using electrically induced contractions of isolated guinea-pig ilea in the absence and presence of increasing concentrations of the selective opioid receptor antagonists CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) (mu) and norbinaltorphimine (kappa). The results showed a similar efficacy and potency for morphine and morphine-6-glucuronide and indicated that both compounds act reversibly, mainly at mu-opioid receptors. It is concluded that morphine and its metabolite morphine-6-glucuronide are equipotent at mu-opioid receptors.
有人提出,阿片类镇痛药吗啡的主要代谢产物吗啡-6-葡萄糖醛酸苷作为镇痛药比母体药物更有效。这一发现似乎并非由于对阿片受体的亲和力不同所致。因此,在本研究中,在有无递增浓度的选择性阿片受体拮抗剂CTAP(D-苯丙氨酸-半胱氨酸-酪氨酸-D-色氨酸-精氨酸-苏氨酸-青霉胺-苏氨酸-NH2)(μ)和去甲丙氧芬(κ)的情况下,使用电刺激诱导的豚鼠离体回肠收缩,在体外比较了吗啡和吗啡-6-葡萄糖醛酸苷的阿片受体介导作用。结果显示吗啡和吗啡-6-葡萄糖醛酸苷具有相似的疗效和效力,并表明这两种化合物均主要通过μ-阿片受体起可逆作用。得出的结论是,吗啡及其代谢产物吗啡-6-葡萄糖醛酸苷在μ-阿片受体上具有同等效力。